The Malaria Control Action Program has helped transition six municipalities in Brazil from high to low-risk malaria zones.
By: Matthew Davis, Burness
By: Rose Catlos, Communications Director, Iavi
By: Rose Catlos, Communications Director, Iavi
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Cristina Donini
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Leslie Jamka, Tyvac, University of Maryland, Baltimore
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
But, our community has researchers, clinicians, and field workers navigating this overwhelming new area where microbiology meets growth physiology.
By: Matthew Davis, Burness
By: Luke Lythgoe, Genomic Surveillance Unit
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: John Bawa, Path, Dr. Rafiq Okine, Who, and Kristen Kelleher, Who
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Alexandra Burgess, Ba, Warren Alpert Medical School of Brown University
By: Stephanie Wilkes Moumtzis, Target Malaria
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
I was at the just concluded Annual Meeting of the American Society for Tropical Medicine and Hygiene (ASTMH) held in Seattle, WA. The topic that received most attention at the conference was the ongoing battle against Malaria, the most challenging public health crisis faced by the mankind.
By: David Walton, Md, Mph
By: Priyanka Patel, Malawi-liverpool Wellcome Trust
By: Scott Gordon, Phd, Path and Mary J. Hamel, M.d., Who
By: Misia Lerska, Burness
By: Hanna Lebuhn, Ba, University of Maryland, Baltimore
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Hanna Lebuhn, Ba, University of Maryland, Baltimore
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Richard Pearson, Phd, Welcome Sanger Institute
By: Mark Gudmastad, Rti International
By: Matthew Davis, Burness
By: Natalie Fecteau, Mph, University of Maryland, Baltimore
By: Matthew Davis, Burness
By: Matthew Davis, Burness
Cambodia, which has the second greatest malaria burden in the Greater Mekong Subregion, aims to reach elimination for malaria-causing parasites Plasmodium falciparum and Plasmodium vivax by 2023 and 2025, respectively. The Cambodia Elimination Project (CMEP) supported by the U.S. President’s Malaria Initiative (PMI) has contributed to this intense national effort leading to remarkable progress.
By: Bridget Desimone, Burness
By: Eric Swedberg, Rashed Shah, and Sara Canavati
Burness science writer Matthew Davis caught up with ASTMH Scientific Program Chair and self-professed “leshmaniac” Christy Petersen, MD, FASTMH, at ASTMH’s headquarters in Arlington, VA during #TropMed21. She shared that one of the most exciting sessions she attended at the Annual Meeting where she explored the use of 3-D technology to visualize cutaneous leishmaniasis.
By: Bridget Desimone, Burness
By: Matthew Davis, Burness
By: Sara Canavati, Save the Children
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Bridget Desimone, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Bridget Desimone, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
Panelists discuss the importance, as well as the limitations, of outbreak science to the COVID-19 response.
By: Maria Luísa Simões, Phd, Johns Hopkins University
By: Emily Owens, The Task Force for Global Health
By: Rebecca Mandt, Phd Candidate, Harvard University
By: Aislinn Mcmillan, Ba, Md Candidate 2022, University of California San Diego School of Medicine
By: Rebecca Mandt, Phd Candidate, Harvard University
By: Laura Kallen, Mph, Path
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Astmh Green Working Group
By: Matthew Davis, Burness
By: Rebecca Mandt, Phd Candidate, Harvard University
By: Rebecca E.k. Mandt, Ba, Harvard T.h. Chan School of Public Health
By: Aislinn Mcmillan, University of California San Diego School of Medicine
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
Learn more about incoming ASTMH President Joel Breman
By: Eve Ameen, Bs, Stony Brook University School of Medicine
By: Bickey Chang, M.h.a., University of Virginia School of Medicine
By: Bickey Chang, M.h.a., University of Virginia School of Medicine
By: Rebecca E.k. Mandt, Ba, Harvard T.h. Chan School of Public Health
By: Austin T. Jones, Mphtm, Md/phd Student, Tulane University
By: Aislinn Mcmillan, University of California San Diego School of Medicine
By: Kristen Zozulin, Md Candidate 2020, Frank H. Netter Md School of Medicine at Quinnipiac University
By: Kristen Zozulin, Md Candidate 2020, Frank H. Netter Md School of Medicine at Quinnipiac University
By: Donal Bisanzio, Phd, Veterinary Medicine, University of Torino
By: Rebecca E.k. Mandt, Ba, Harvard T.h. Chan School of Public Health
By: Chelsea Toledo, Ma, Ntd Support Center
By: Kristen Zozulin, Md Candidate 2020, Frank H. Netter Md School of Medicine at Quinnipiac University
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Charlotte Ward, Malaria Consortium
By: Matthew Davis, Burness
By: Joanne Morrison, University of Maryland School of Medicine
By: Rebecca E.k. Mandt, Ba, Harvard T.h. Chan School of Public Health
By: Matthew Davis, Burness
By: Aislinn Mcmillan, University of California San Diego School of Medicine
By: Bickey Chang, M.h.a., University of Virginia School of Medicine
By: Kristen Zozulin, Md Candidate 2020, Frank H. Netter Md School of Medicine at Quinnipiac University
By: Joanne Morrison, University of Maryland School of Medicine
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Matthew Davis, Burness
By: Leslie Jamka, Mem, Ms, Center for Vaccine Development and Global Health (cvd) at the University of Maryland School of Medicine
By: Scott Mcpherson, Mph, Act to End Ntds | East, Rti International
By: Julie Jacobson, Md, Dtmh, Astmh
By: Chandy C. John, Md, Ms, Astmh President
By: Matthew Davis, Burness
By: Chandy C. John, Md, Ms, Astmh President
By: Anne Rimoin, Ph.d., M.p.h.
By: Astmh
By: M. Claudia Guezala V. Dvm, Phd.
By: A. Desiree Labeaud Associate Professor of Pediatrics (infectious Diseases), Stanford University
By: Abdoulaye Djimdé, Pharmd, Phd
Seth Judson discusses his experience with the ASTMH annual meeting, and his time in New Orleans.
By: Caitlin Christman, Malaria Technical Advisor, U.s. President’s Malaria Initiative
By: Catherine Gulley, Sabin Vaccine Institute
By: Matthew Davis, Burness
By: Chandy C. John, Md, Ms, Astmh President
Andrea Stewart discusses updates in antimalarial resistance during TropMed18.
By: Andrea-stewart
By: Mellisa Roskosky
By: Bridget Desimone, Burness
By: Leslie Jamka, Mem, Ms, Center for Vaccine Development and Global Health (cvd) at the University of Maryland School of Medicine
By: Lisa Goldman-van Nostrand
By: Mellisa Roskosky
By: Eric Mintz, Md, Mph - Team Lead, Global Epidemiology Waterborne Diseases Prevention Branch, Cdc
By: Dr. Nihal Abeysinghe & Dr. Kathy Neuzil
As we mark the 100th Anniversary of 1918 Flu Pandemic – What’s Next Big One?
By: Matthew Davis, Burness
By: Mark Jones
By: Ingrid Peterson, Assistant Professor, University of Maryland School of Medicine
By: Matthew Davis, Burness
By: Bridget Desimone, Burness
By: Kristina Burrack
By: Martin Alilio Operational Research Coordinator U.s. President’s Malaria Initiative
By: Brice Campo, Director, Drug Discovery at Mmv